20 Stocks Moving In Monday's Pre-Market Session

Gainers

• Synthorx, Inc. THOR shares rose 167.7% to $67.00 in pre-market trading after the company announced it would be acquired by Sanofi for $68 per share in cash.
• XBiotech Inc. XBIT shares rose 148.7% to $27.65 in pre-market trading after the company announced it would license its anti-inflammatory antibody to Janssen for $750 million in cash and up to $600 million in milestone payments.
• ArQule, Inc. ARQL shares rose 101.7% to $9.49 in pre-market trading after the company agreed to be acquired by Merck & Co., Inc. MRK for $20 per share in cash.
• ObsEva SA OBSV rose 51.4% to $6.92 in pre-market trading after reporting positive results from uterine fibroids Phase 3 study (PRIMROSE 2) of linzagolix.
• Fate Therapeutics, Inc. FATE shares rose 25.8% to $17.20 in pre-market trading after the company disclosed that combination of FT596 with rituximab showed durable tumor clearance in vivo in preclinical lymphoma model at the ASH 2019.
• TG Therapeutics, Inc. TGTX rose 24% to $8.83 in pre-market trading after the company announced a 100% overall response rate in its phase 1/2 study of ublituximab.
• PG&E Corporation PCG rose 21.2% to $11.70 in pre-market trading after the company announced it reached a $13.5 billion settlement to resolve individual claims from recent fires including the 2018 Camp Fire and 2017 Tubbs fire.
• Repro Med Systems, Inc. KRMD shares rose 11.8% to $5.51 in pre-market trading.
• Roadrunner Transportation Systems, Inc. RRTS rose 10.9% to $10.20 in pre-market trading after the company reported the sale of its Flatbed Business unit for $30 million in cash.
• Summit Midstream Partners, LP SMLP rose 10.7% to $3.20 in pre-market trading bid.
• Franco-Nevada Corporation FNV rose 8.2% to $105.00 in pre-market trading.
• bluebird bio, Inc. BLUE rose 6.4% to $84.50 in pre-market trading. bluebird bio presented new data from ongoing Phase 1/2 HGB-206 study of LentiGlobin gene therapy for sickle cell disease at the ASH 2019.
• LG Display Co., Ltd. LPL rose 5.8% to $6.59 in pre-market trading.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Diplomat Pharmacy, Inc. DPLO fell 31.7% to $3.97 in pre-market trading. UnitedHealth Group Inc UNH announced plans to buy Diplomat Pharmacy for around $300 million.
• KalVista Pharmaceuticals, Inc. KALV fell 30.2% to $10.00 in pre-market trading after the company disclosed that its Phase 2 trial of KVD001 did not meet its primary endpoint.
• Datadog, Inc. DDOG fell 4.2% to $34.40 in pre-market trading.
• Kosmos Energy Ltd KOS fell 4% to $5.80 in pre-market trading.
• DarioHealth Corp. DRIO fell 3.8% to $8.36 in pre-market trading.
• Target Corporation TGT fell 3.4% to $120.77 in pre-market trading.
• RedHill Biopharma Ltd. RDHL shares fell 3.3% to $6.36 in pre-market trading.